In Missouri, J&J faces biggest trial yet alleging talc caused cancer
NEW YORK (Reuters) – A lawsuit by 22 ovarian cancer patients against Johnson & Johnson went to trial on Wednesday in Missouri state court, marking the largest case the company…
Drug combination better for restoring womb after miscarriage
(Reuters Health) – Two drugs are better than one when it comes to restoring the womb after an incomplete miscarriage, according to a new study. The 300 women in the…
Medical workers in Congo city finish vaccinating contacts of Ebola patients
KINSHASA (Reuters) – Medical workers in Democratic Republic of Congo have given all the immediate contacts of Ebola patients in the city of Mbandaka an experimental vaccine as they try…
Many women with early-stage breast cancer can skip chemotherapy: study
CHICAGO (Reuters) – Some 70 percent of women with early-stage breast cancer and an intermediate risk of cancer recurrence can safely skip chemotherapy after their tumors have been removed, U.S.…
Experts outline ethics issues with use of genealogy DNA to solve crimes
(Reuters Health) – With recent revelations that U.S. law enforcement can – and already has – dipped into consumer genealogy DNA databases to help solve crimes, experts say more discussion…
Novartis readies anti-sexism message for migraine drug
ZURICH (Reuters) – With women hardest hit by migraine headaches, Swiss drugmaker Novartis is gearing up its marketing message to counteract sexism that it worries might become a barrier to…
Leading oncology group wary of Trump drug price proposals
CHICAGO (Reuters) – America’s leading group of cancer doctors is wary of new Trump administration proposals for lowering drug costs, warning that patients must not be barred from medicines that…
TherapeuticsMD’s therapy for menopause-related condition gets approval
(Reuters) – Women’s healthcare company TherapeuticsMD Inc won its first-ever U.S. approval on Wednesday with the drug regulator clearing its hormone therapy for a painful condition triggered by menopause after…
WHO’s Congo Ebola plan assumes 100-300 cases over three months
GENEVA (Reuters) – The World Health Organization assumes 100-300 cases of Ebola in Democratic Republic of Congo between May and July, under a revised response plan to the outbreak that…
India steps up hunt for origin of mysterious brain-damaging virus
MUMBAI/KOCHI (Reuters) – India began a fresh round of tests to trace the origin of a rare brain-damaging virus that has killed 13 people, a health official said on Monday,…